Form 8-K - Current report:
SEC Accession No. 0001193125-25-142384
Filing Date
2025-06-18
Accepted
2025-06-18 08:00:26
Documents
13
Period of Report
2025-06-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d51841d8k.htm   iXBRL 8-K 47038
2 EX-10.1 d51841dex101.htm EX-10.1 155782
  Complete submission text file 0001193125-25-142384.txt   359663

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA advm-20250617.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE advm-20250617_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE advm-20250617_pre.xml EX-101.PRE 10813
16 EXTRACTED XBRL INSTANCE DOCUMENT d51841d8k_htm.xml XML 3516
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 251055153
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)